Microsoft word - 20111028 lu_cv_english to web.doc
Lu Chi-Yu
Present position Assistant Professor (Current) Department of Biochemistry, Kaohsiung Medical University Work Experience Postdoctoral Research Fellow in Proteomics Research Center, National Yang-Ming University Degree Graduate Institute of Pharmaceutical Sciences, Kaohsiung
Medical University School of Pharmacy, Kaohsiung Medical University
Research Fields Pharmaceutical and Biomedical analysis, Micro-scale analysis, Proteomics, Metabolite analysis, Mass spectrometry, Biomarker analysis Publications (2006 ~)
S. E. Peng, W. N. Chen, H. K. Chen, C. Y. Lu, A. B. Mayfield, L. S. Fang and C. S. Chen*, Lipid bodies in coral-dinoflagellate endosymbiosis: proteomic and ultrastructural studies. Proteomics 2011, 11, 3540-3555.
Z. Y. Tsai , C. H. Chou, C. Y. Lu, S. Singh, S. L. Yu and S. S. Li*, Proteomic comparison of human embryonic stem cells with their differentiated fibroblasts: Identification of 206 genes targeted by hES cell-specific microRNAs. Kaohsiung J. Med. Sci., 2011, 27, 299-306.
C. L. Kao*, Y. H. Tang, Y. C. Lin, L. T. Chiu, H. T. Chen, S. C. Hsu, K. C. Hsieh, C. Y. Lu and Y. L. Chen, Copper Complex of a Pyridine-Modified Poly(amidoamine) Dendrimer as a Chemical Nuclease: Synthetic and Catalytic Study. Nanomedicine, 2011, 7, 273-276. (SCI)
A. M. Huang*, Y. T. Kao, S. Toh, P. Y. Lin, C. H. Chou, H. T. Hu, C. Y. Lu, J. Y. Liou, S. Y. Chao, T. C. Hour and Y. S. Pu, UBE2M-mediated p27(Kip1) Degradation in Gemcitabine Cytotoxicity. Biochem. Pharmacol., 2011, 82, 35-42. (SCI)
S. F. Cho, T. C. Liu, C.Y. Lu and C. S. Chang*, Epidural Leukemic Involvement and Intracranial Hemorrhage as Initial Manifestations in a Newly Diagnosed Chronic Myeloid Leukemia Patient. Ann. Hematol., 2011, 90, 607-609. (SCI)
6. C. H. Feng, H. Y. Huang and C. Y. Lu*, Quantitation of the
Glutathione in Human Peripheral Blood by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry Coupled with Micro-scale Derivatization. Anal. Chim. Acta, 2011, 690, 209-214. (SCI)
C. H. Feng and C. Y. Lu*, Modification of Major Plasma Proteins by Acrylamide and Glycidamide: Preliminary Screening by Nano Liquid Chromatography with Tandem Mass Spectrometry. Anal. Chim. Acta, 2011, 684, 80-86. (SCI)
C. Y. Lu and C. H. Feng*, Quantitation of Irbesartan and Major Proteins in Human Plasma by Mass Spectrometry with Time-of-Flight Analyzer. J. Pharm. Biomed. Anal., 2011, 54, 100-105. (SCI)
C. H. Feng, C. H. Chou, L. Y. Chuang and C. Y. Lu*, Identification of the Metabolites of Angiotensin II (1-8) in MES-13 Cells by a Simple NanoLC-MS-MS System: a Preliminary Platform. Anal. Lett., 2011, 44, 1187-1196. (SCI)
10. C. H. Feng, C. H. Chou, L. Y. Chuang and C. Y. Lu*, Protein
Identification from Two-Dimensional Gel Electrophoresis by Connecting ZipTip with a Home-Assembled Nanoflow System. Microchim. Acta 2010, 170, 179-185. (SCI)
11. H. L. Cheng, S. S. Chiou, Y. M. Liao, C. Y. Lu, Y. L. Chen and S.
M. Wu*, Analysis of Methotrexate and Its Eight Metabolites in Cerebrospinal Fluid by Solid-Phase Extraction and Triple-Stacking Capillary Electrophoresis. Anal. Bioanal. Chem. 2010, 398, 2183-2190. (SCI)
12. Y. P. Lin, M. E. Hsu, Y. Y. Chiou, H. Y. Hsu, H. C. Tsai, Y. J. Peng,
C. Y. Lu, C. Y. Pan, W. C. Yu, C. H. Chen, C. W. Chi and C. H. Lin*, Comparative Proteomic Analysis of Rat Aorta in a Subtotal Nephrectomy Model. Proteomics 2010, 10, 2429-2443. (SCI)
13. H. H. Yeh, H. L. Wu, C. Y. Lu, and S. H. Chen*, Simultaneous
Determination of Regular Insulin and Insulin Aspart by Capillary Zone Electrophoresis and Application in Drug Formulations. J. Pharm. Biomed. Anal., 2010, 53, 145-150. (SCI)
14. C. H. Feng and C. Y. Lu*, A Micro-Scale Model to Monitor the
Major Proteins in Human Urine before and after Medication with Angiotensin-Converting Enzyme Inhibitor: a Preliminary Study. Anal. Lett., 2010, 43, 2705-2715. (SCI)
15. C. Y. Lu, Y. R. Wang, S. H. and Chen C. H. Feng*, Analysis of
Quinapril by Two Solvent Saving Methods: Application of Capillary Liquid Chromatography and LDI-TOF MS. J. AOAC Int., 2010, 93, 1201-1206. (SCI)
16. S. E. Peng, Y. B. Wang, L. H. Wang, W. N. U. Chen, C. Y. Lu, L. S.
Fang and C. S. Chen*, Proteomic Analysis of Symbiosome Membranes in Cnidaria-Dinoflagellate Endosymbiosis. Proteomics 2010, 10, 1002-1016. (SCI)
17. C. H. Feng, C. M. Yang and C. Y. Lu*, Trace Analysis of
Glyclazide in Human Plasma at Micro-Scale Level by Mass Spectrometry. J. Sep. Sci., 2009, 32, 3411-3417. (SCI)
18. C. H. Feng and C. Y. Lu*, A New Matrix for Analyzing Low
Molecular Mass Compounds and Its Application for Determination of Carcinogenic Areca Alkaloids by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry. Anal. Chim. Acta, 2009, 649, 230-235. (SCI)
19. K. C. Hsien, H. T. Chen, Y. C. Chen, Y. L. Chen, C. Y. Lu and C. L.
Kao*, Pyridoxal 5’-Phosphate Binding in Lysine-Modified PAMAM Dendrimers: A Biomimetic Approach. Org. Lett., 2009, 11, 3526-3529. (SCI)
20. C. Y. Lu, Y. M. Chang, W.L. Tseng C. H. Feng* and C. Y. Lu,
Analysis of Angiotensin II Receptor Antagonist and Protein Markers at Microliter Level Plasma by LC-MS/MS. J. Pharm. Biomed. Anal., 2009, 49, 123-128. (SCI)
21. S. F. Wu, P. W. Hsieh, C. C. Wu, C. L. Lee, S. L. Chen, C. Y. Lu, T.
S. Wu, F. R. Chang and Y. C. Wu, Camptothecinoids from the Seeds of Taiwanese Nothapodytes foetida. Molecules, 2008, 13, 1361-1371. (SCI)
22. C. Y. Lu and C. H. Feng*, Determination of Clinically Very Basic
Compounds by Nanoscale Liquid Chromatography with Tandem
Mass Spectrometry. J. Liq. Chromatogr. Relat. Technol., 2008, 31, 54-63. (SCI)
23. C. Y. Lu, C. Y. Wu and C. H. Lin*, Protein Identification by a
Syringe Pump-driven Reversed-phase LC-MS/MS. Anal. Biochem., 2007, 638, 123-129. (SCI)
24. W. J. Chung, H. Y. Shu, C. Y. Lu, C. Y. Wu, Y. H. Tseng, S. F. Tsai
and C. H. Lin*, Qualitative and Comparative Proteomic Analysis of Xanthomonas campestris pv. Campestris 17. Proteomics, 2007, 7, 2047-2058. (SCI)
25. C. Y. Lu and C. H. Feng*, Micro-scale Analysis of Aminoglycoside
Antibiotics in Human Plasma by Capillary Liquid Chromatography and Nanospray Tandem Mass Spectrometry with Column Switching. J. Chromatogr. A, 2007, 1156, 249-253. (SCI)
26. C. Y. Lu and C. H. Feng*, Identification of Dimer Impurities in
Ampicillin and Amoxicillin by Capillary LC and Tandem Mass Spectrometry. J. Sep. Sci., 2007, 30, 329-332. (SCI)
27. C. Y. Lu and C. H. Feng*, On-line Concentration of Neomycin and
Screening Aminoglycosides in Milk by Short Capillary Column and Tandem mass Spectrometry. J. Sep. Sci., 2006, 29, 2143-2148. (SCI)
Exelon launches new brand strategy and logo following recent merger with Constellation CHICAGO (May 24, 2012) — Exelon Corporation today revealed its new brand strategy, including the new corporate vision and values that will guide the energy company going forward, as well as a new logo and visual identity, following Exelon’s recent merger with Constellation. “Together, Exelon and
Product: 655-812 Prentox® Perm-X™ UL 31-66 Material Safety Data Sheet U.S. Department of Labor (OSHA 29 CFR 1910.1200) Manufacturer's Name: Prentiss Incorporated C. B. 2000 Floral Park, NY 11001 Telephone Number: (516) 326-1919 Section 1: Chemical Identification Product: 655-812 Prentox® Perm-X™ UL 31-66 EPA Signal Word: CAUTION Active Ingredients (%): Permethrin (31%)